Chia seeds have become the go-to omega-3 source for plant-based athletes. The marketing is compelling: a single 28g serving delivers 5g of alpha-linolenic acid (ALA), more than twice the RDA. But the assumption that ALA from chia converts to the EPA and DHA your muscles and brain actually need — in meaningful quantities — is one of the most consequential misunderstandings in plant-based sports nutrition.
The problem is a single enzyme. Delta-6-desaturase (FADS2) is the rate-limiting step in the conversion of ALA to eicosapentaenoic acid (EPA), and from EPA to docosahexaenoic acid (DHA). The enzyme is not exclusive to ALA — it also processes linoleic acid (omega-6), the most abundant fatty acid in most Western diets. Because omega-6 intake is typically 10–20× higher than ALA intake, FADS2 is competitively inhibited, and the conversion of ALA to EPA is severely restricted.
---
Burdge and Calder (2005) quantified this conversion rate in detail. In young men, approximately 5–10% of ALA is converted to EPA, and less than 0.5–1% reaches DHA. In women, the conversion rate is modestly higher due to oestrogen upregulating FADS2 activity — still insufficient to produce therapeutic tissue concentrations from plant sources alone. A 28g serving of chia seeds therefore delivers approximately 250–500mg of effective EPA equivalent — a fraction of the 1–2g EPA+DHA daily target supported by the anti-inflammatory and mTORC1 sensitisation literature for athletes.
Genetics add further interindividual variability. The FADS1 rs174537 and FADS2 rs3834458 polymorphisms affect enzymatic activity across the desaturation pathway. Individuals with the major (GG) allele at rs174537 maintain higher conversion capacity; minor allele homozygotes (AA) have significantly impaired conversion and may produce under 2% of ALA as EPA. Without genotyping, you cannot know where you fall — making dietary gambles on ALA sufficiency particularly risky.
---
The competitive inhibition mechanism is dietary and therefore modifiable. Reducing dietary omega-6 (primarily from refined seed oils: sunflower, safflower, corn, soy) while maintaining ALA intake shifts the FADS2 substrate competition in ALA's favour. However, even optimised conversion in low-omega-6 individuals still falls short of the tissue EPA and DHA concentrations achievable through direct long-chain supplementation.
Algae oil provides the cleanest solution for plant-based athletes. Marine algae (primarily *Schizochytrium* species) are the original biosynthetic source of DHA — fish accumulate DHA by eating algae or smaller fish that do. Algae-derived DHA supplements provide 200–500mg DHA per capsule, with some formulations also providing EPA. Bioavailability of algal DHA is equivalent to fish oil (Arterburn et al., 2008), and the environmental footprint is substantially lower. For EPA specifically, some algae strains (notably *Nannochloropsis*) provide EPA directly, though commercial availability is more limited.
---
The muscle physiology rationale for EPA+DHA in plant-based athletes extends beyond anti-inflammatory DOMS reduction. Smith et al. (2011) demonstrated that omega-3 supplementation (3.36g/day EPA+DHA for 8 weeks) sensitised mTORC1 signalling to amino acid stimulation, increasing protein synthesis rates by 25% at matched protein intakes. For plant-based athletes already working against lower leucine density per gram of most plant proteins, enhancing the mTORC1 sensitivity of the anabolic signalling pathway has meaningful compounding effects on net muscle protein accretion over training cycles.
For athletes using plant proteins and working to optimise amino acid quality and completeness, combining this omega-3 strategy with a careful review of protein intake targets is essential. The calculator at winsport.uk/tools/nutrition/protein-intake-muscle-gain estimates daily protein requirements adjusted for goal, body weight, and training frequency — providing the intake baseline to which optimised omega-3 status can be applied for maximal anabolic signalling.
Is your plant-based omega-3 strategy built around ALA sources, algae oil, or a combination? What does your current approach look like?